Image from CNBC.com |
In the study, published in JAMA Network Open, 474 participants reported a history of such allergic reactions, and significantly more suffered from allergic reactions following the mRNA vaccine than those who did not report a history of allergic reactions, 11.6% to 4.7%. The most common reaction was swelling in the skin. Despite these symptoms, 97.6% of the employees received two doses of an mRNA vaccine.
Lily Li, the study's lead author, said, "The results of this study can help guide expectations for patients with high-risk allergy histories. Symptoms such as hives and swelling may occur, particularly with the first vaccine dose, but most reported allergic symptoms did not impede completion of the two-dose mRNA vaccine series."
No comments:
Post a Comment